Arechar Healthcare announces the launch of an effective solution for patients with prostate cancer, with the widespread distribution of Enzalutamide, under the brand name Enzalu. Witnessing the greater demands of medicines in the oncology sector, Arechar focussed on creating efficacious treatment strategies for patients all over the world. The manufacturing units of the company gave a clear picture of the high-quality medicines, with 100% reliability.
Enzalutamide, sold under the brand name Enzalu, is a nonsteroidal antiandrogen medicine, used to treat prostate cancer. It acts as a selective silent antagonist of the AR (androgen receptor).
Enzalu has greatly increased efficacy as an antiandrogen, as compared to the “first generation” NSAA, and therefore Enzalutamide is regarded as the “second generation” NSAA.
Enzalu (Enzalutamide) has approximately 8-fold higher binding affinity for the androgen receptor. It is a synthetic diarylthiohydantoin derivative. It is structurally related to the “first generation” NSAA. The molecular formula of the active ingredient of Enzalu (Enzalutamide) is C21H16F4N4O2S. Its molecular weight is 464.4 g/mol.
Enzalu (Enzalutamide) is available in the form of tablets for oral consumption in the strength of 40 mg. It should be swallowed as a whole with water, without breaking, chewing, or crushing the tablet.
“Speaking of what 2021 holds for Arechar Healthcare, I would like to introduce Enzalu, Enzalutamide for the treatment of prostate cancer, opening the doors for accessible life-saving drugs, in the oncology sector, as it has been evident that the cases of cancer are increasing with a higher rate,” said Mr. Harpreet Singh, Founder of Arechar Healthcare.
“With the growing incidence of cancer in the world, I commit to serve humanity with the same beliefs of creating the best solutions for the treatment of the patients. I feel delighted with this launch because prostate cancer has proved to be one of the most deadly cancers in males,” he added.
“Words have always been less to show our dedication towards the oncology sector. We are highly devoted to providing greater access to life-saving drugs to the patients,” said Mrs. Ruchika Rajbans, Co-Founder of Arechar Healthcare.
About Arechar Healthcare
Arechar Healthcare is one of the largest leading manufacturers of life-saving drugs, working to serve the patients with the best and approved life-saving drugs at an affordable range of prices. It has attained an authoritative position worldwide in the field of Pharma. It has successfully extended its reach globally and is working with immense insight into humanity. Very few manufacturers possess the drive and determination that the Arechar Healthcare Team has displayed, ever since it started. Focussing on the accessibility and efficacy of life-saving drugs, Arechar Healthcare aims to strengthen the healing and treatment process, with a major focus on oncology care and other diseases that threaten human lives.
Related hot topics
Bortecine, an effective drug for Blood cancer
Bortecine, for Multiple Myeloma and Mantle Cell Lymphoma
Arechar Healthcare provides independent and precise information about prescription drugs with the related news and press releases. This content is displayed for informational purposes only and is not intended to be an alternative for any medical advice/prescription or treatment. Do not delay or ignore any medical treatment owing to something you’ve read or seen on this website. Also, this website offers links to other websites, enabling the viewers to directly switch to that website for detailed information or accurate references. Thus, Arechar is not responsible for the content displayed on the linked websites or the content of the links in the linked website.